These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30402882)

  • 1. Diagnostic approach with genetic tests for global developmental delay and/or intellectual disability: Single tertiary center experience.
    Han JY; Jang W; Park J; Kim M; Kim Y; Lee IG
    Ann Hum Genet; 2019 May; 83(3):115-123. PubMed ID: 30402882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability.
    Flore LA; Milunsky JM
    Semin Pediatr Neurol; 2012 Dec; 19(4):173-80. PubMed ID: 23245550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of intellectual disability/global developmental delay via genetic analysis in a central region of China.
    Liao LH; Chen C; Peng J; Wu LW; He F; Yang LF; Zhang CL; Wang GL; Peng P; Ma YP; Miao P; Yin F
    Chin Med J (Engl); 2019 Jul; 132(13):1533-1540. PubMed ID: 31205075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Yield of Intellectual Disability Gene Panels.
    Pekeles H; Accogli A; Boudrahem-Addour N; Russell L; Parente F; Srour M
    Pediatr Neurol; 2019 Mar; 92():32-36. PubMed ID: 30581057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Our experience with the aetiological diagnosis of global developmental delay and intellectual disability: 2006-2010.
    López-Pisón J; García-Jiménez MC; Monge-Galindo L; Lafuente-Hidalgo M; Pérez-Delgado R; García-Oguiza A; Peña-Segura JL
    Neurologia; 2014 Sep; 29(7):402-7. PubMed ID: 24332781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.
    Li Y; Anderson LA; Ginns EI; Devlin JJ
    Mol Diagn Ther; 2018 Feb; 22(1):129-138. PubMed ID: 29209992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
    Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
    Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of global developmental delay and intellectual disability in Ukrainian children.
    Shchubelka K; Turova L; Wolfsberger W; Kalanquin K; Williston K; Kurutsa O; Makovetska A; Hasynets Y; Mirutenko V; Vakerych M; Oleksyk TK
    J Neurodev Disord; 2024 Mar; 16(1):13. PubMed ID: 38539105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil.
    Leite AJDC; Pinto IP; Leijsten N; Ruiterkamp-Versteeg M; Pfundt R; de Leeuw N; da Cruz AD; Minasi LB
    PLoS One; 2022; 17(4):e0266493. PubMed ID: 35390071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Michelson DJ; Shevell MI; Sherr EH; Moeschler JB; Gropman AL; Ashwal S
    Neurology; 2011 Oct; 77(17):1629-35. PubMed ID: 21956720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic characteristics and prenatal diagnosis of patients presented GDD/ID with rare monogenic causes.
    Lin L; Zhang Y; Pan H; Wang J; Qi Y; Ma Y
    Orphanet J Rare Dis; 2020 Nov; 15(1):317. PubMed ID: 33176815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome sequencing demonstrates high diagnostic yield in children with undiagnosed global developmental delay/intellectual disability: A prospective study.
    Sun Y; Peng J; Liang D; Ye X; Xu N; Chen L; Yan D; Zhang H; Xiao B; Qiu W; Shen Y; Pang N; Liu Y; Liang C; Qin Z; Luo J; Chen F; Wang J; Zhang Z; Wei H; Du J; Yan H; Duan R; Wang J; Zhang Y; Liao S; Sun K; Wu L; Yu Y
    Hum Mutat; 2022 May; 43(5):568-581. PubMed ID: 35143101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Chromosomal Microarray in Children with Unexplained Developmental Delay/Intellectual Disability.
    Kamath V; Yoganathan S; Thomas MM; Gowri M; Chacko MP
    Fetal Pediatr Pathol; 2022 Apr; 41(2):208-218. PubMed ID: 32701375
    [No Abstract]   [Full Text] [Related]  

  • 15. The second-tier status of fragile X syndrome testing for unexplained intellectual disability/global developmental delay in the era of next-generation sequencing.
    Zhang W; Li D; Pang N; Jiang L; Li B; Ye F; He F; Chen S; Liu F; Peng J; Yin J; Yin F
    Front Pediatr; 2022; 10():911805. PubMed ID: 35935362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.
    Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH
    Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of single nucleotide polymorphism-microarray and target gene sequencing in the study of genetic etiology of children with unexplained intellectual disability or developmental delay].
    Gao ZJ; Jiang Q; Cheng DZ; Yan XX; Chen Q; Xu KM
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):740-745. PubMed ID: 27784475
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the Griffiths mental development scale-Chinese in the assessment of children with autism spectrum disorder and global developmental delay/intellectual disability.
    Wang H; Du Y; Mao Z; Che Y; Li H; Ding L; Jin H
    Medicine (Baltimore); 2021 Apr; 100(13):e25407. PubMed ID: 33787650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Next-Generation Sequencing of Korean Patients With Developmental Delay and/or Intellectual Disability.
    Han JY; Jang JH; Park J; Lee IG
    Front Pediatr; 2018; 6():391. PubMed ID: 30631761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.